The advent of genome-based medicine and pharmacogenomics (the medical field that analyzes the reasons why people have different reactions to similar treatment) is expected to transform the medical regulatory environment in Japan. As the human genome is decoded, development of new medicines... Read More
India is the world’s second most populous country after China, with a total population of about 1 billion. While much of India is rural and poor (over 70 percent of the population lives in rural areas and the per capita income is... Read More
The Taiwanese government has promised to invest US$1.6 billion for biotechnology research and development projects over the next several years. This is in addition to the approximately US$4 billion private Taiwanese companies have invested in this sector (a significant portion of private... Read More
With 2000 sales over US$1 billion and demand for medical devices predicted to grow by 10% in 2001, South Korea is Asia’s second largest medical device market, after Japan. Imports from the United States increased nearly 60% in 2000 to US$308 million... Read More
The pharmaceutical market in the Philippines is expected to grow 5% this year, to $294 million. Poverty and pollution both help to contribute to especially high incidences of diseases such as respiratory infections, cardiovascular disease, and diseases of the central nervous system.... Read More
The Japanese medical market is on the rebound and is expected to grow to 6% annually over the next several years. With 20% of the population over the age of 65 and a growing number of diseases like cancer and heart disease... Read More
Southeast Asia is becoming an increasingly important market for medical products, including products for diagnosing and treating infectious diseases. Pharmaceutical and diagnostics firms can take advantage of shorter regulatory procedures required in Brunei, Cambodia, Indonesia, Laos, Myanmar, the Philippines, Singapore, Thailand, and... Read More
In the U.S., the culture and the civil negligence liability system dictates that doctors and hospitals disclose to prospective patients what the illness and proposed course of treatment are, including the benefits and risks. Generally speaking, patients in the U.S. and their... Read More
The growth rate of HIV and AIDS cases in Asia is the highest in the world. The dynamic nature of the Southeast Asian markets, in conjunction with the rapid spread of HIV and AIDS has spawned a region of incredible potential for... Read More
Japan's contact lens market was worth 50.8 billion (about $508 million) in 1995. A total of around 30 contact lens manufacturers operate in Japan, including foreign companies. The top five, including Bausch & Lomb, account for 70% of the market. Eye doctors... Read More